P1/2, N=94, Recruiting, M.D. Anderson Cancer Center | Trial completion date: Aug 2023 --> Aug 2026 | Trial primary completion date: Aug 2023 --> Aug 2026
over 1 year ago
Trial completion date • Trial primary completion date
|
cyclophosphamide • fludarabine IV • CAR.70/IL15-transduced CB-NK cells